Listen to the podcast by either clicking the 'play' button above, searching for AccountingWEB in your favourite podcast app ...
Panelists discuss how IDH inhibitors, particularly ivosidenib combined with azacitidine, represent potentially the greatest ...
Panelists discuss how combination trials like VIALE-A and VIALE-C have demonstrated venetoclax’s survival benefits when added ...
Key insight: The agency predicts it will collect voluntary survey data on anti-money-laundering compliance costs from hundreds of thousands of nonbank institutions. Supporting Data: The agency expects ...
There is a palpable tension that governs most financial crime programs in the United States. Banks build their AML programs on the principle of risk-based compliance. They say it to regulators, write ...
Senator Chris Murphy (D-CT) has slammed the White House as a "full time, 24/7 corruption machine." Murphy's outburst against ...
CORRECTION (Oct. 18, 3:50PM UTC): Corrects headline and article throughout to say Coinhouse and not Coinbase was part of the exchanges that were targeted by the French regulator. France is targeting ...
Revuforj is approved for relapsed/refractory AML with NPM1 mutation in patients aged one year and older, based on AUGMENT-101 trial results. The drug inhibits menin's interaction with KMT2A, slowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback